Medicare Enrolled

Dr. Robert Ball, D.O.

Pain Medicine · Port Charlotte, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
19621 COCHRAN BLVD, Port Charlotte, FL 33948
9416279095
In practice since 2008 (17 years)
NPI: 1841454477 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ball from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ball? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ball

Dr. Robert Ball is a pain medicine in Port Charlotte, FL, with 17 years in practice. Based on federal Medicare data, Dr. Ball performed 10,331 Medicare services across 4,060 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ball received a total of $222,634 from 40 pharmaceutical and/or device companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ball is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 9% volume in FL$ $222,634 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,331
Medicare services
Top 9% in FL for pain medicine
4,060
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~608 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, midazolam hydrochloride, per 1 mg1,699$0$5
Betamethasone steroid injection1,247$5$13
Office visit, established patient (20-29 min)1,169$63$263
Contrast dye for imaging, lower concentration1,155$0$15
Dexamethasone injection (steroid)1,030$0$2
Injection, methylprednisolone acetate, 80 mg683$9$55
Drug screening test354$61$238
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes354$38$146
Injection of lower or sacral spine facet joint using imaging guidance, single level227$177$683
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes227$9$32
Injection of lower or sacral spine facet joint using imaging guidance, second level217$95$355
Injection of substance into lower spine canal using imaging guidance150$192$756
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint150$449$1,739
Injection, methylprednisolone acetate, 40 mg146$6$55
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint144$251$942
New patient office visit (45-59 min)130$125$497
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level123$208$801
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance121$141$590
Injection of upper or middle spine facet joint using imaging guidance, single level106$176$694
Injection of upper or middle spine facet joint using imaging guidance, second level104$94$354
Steroid injection (triamcinolone)104$1$5
Joint injection, major joint91$53$211
Fluoroscopic guidance for needle placement87$87$338
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level85$87$330
New patient office visit, complex (60-74 min)58$168$656
Destruction of nerves supplying joint between spine and pelvis using imaging guidance54$344$1,366
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint49$350$1,363
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint49$210$795
Office visit, established patient (30-39 min)40$96$378
Injection of trigger points, 1-2 muscles37$39$164
Injection of substance into middle or upper spine canal using imaging guidance29$196$765
Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level25$242$911
Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones25$362$1,416
Injection of trigger points, 3 or more muscles19$46$197
Office visit, established patient, complex (40-54 min)16$136$525
Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin14$758$3,200
Heat destruction of intraosseous basivertebral nerve in additional bone of spine in lower back13$175$667
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$222,634
Total received (2018-2024)
Avg $31,805/year across 7 years
Top 1% in FL for pain medicine
40
Companies
552
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$191,330 (85.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,048 (9.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,257 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$50,454
2023
$85,560
2022
$42,078
2021
$9,251
2020
$4,279
2019
$2,923
2018
$28,089

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Relievant Medsystems, Inc.
$134,688
Boston Scientific Corporation
$49,054
Abbott Laboratories
$17,207
Vertiflex, Inc.
$7,664
Nevro Corp.
$7,061
Medtronic USA, Inc.
$2,072
Stryker Corporation
$841
PAINTEQ LLC
$738
Vertos Medical, Inc.
$508
Medtronic, Inc.
$454
VGI Medical, LLC
$387
MML US, Inc.
$288
Nalu Medical, Inc.
$272
Stimwave Technologies Incorporated
$223
Flowonix Medical Incorporated
$155
BOSTON SCIENTIFIC CORPORATION
$121
AbbVie Inc.
$83
Allergan, Inc.
$71
ABBVIE INC.
$70
SI-BONE, INC.
$61
Merit Medical Systems Inc
$53
Allergan Inc.
$53
US WorldMeds, LLC
$51
SPR Therapeutics, Inc
$43
Flexion Therapeutics, Inc.
$43
Curonix LLC
$40
Lundbeck LLC
$38
Teva Pharmaceuticals USA, Inc.
$33
Jazz Pharmaceuticals Inc.
$33
Almatica Pharma LLC
$32
Avanos Medical
$28
Averitas Pharma Inc.
$26
PFIZER INC.
$26
Amgen Inc.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Spinal Simplicity, LLC
$19
Shionogi Inc
$19
Daiichi Sankyo Inc.
$17
Novartis Pharmaceuticals Corporation
$14
Saluda Medical Americas, Inc.
$9
Top 3 companies account for 90.3% of total payments
Associated products mentioned in payments ›
AJOVY · Axium INS DRG IPG · BOTOX · BOTOX THERAPEUTIC · COOLIEF* COOLED RADIOFREQUENCY · DRG IPGs · DRG leads · ETERNA · Evoke · G4 RF Generator · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · General - Pain Management · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - VERTEBRAL AUGMENTATION PRODUCTS · Intracept · KYPHON Balloon Kyphoplasty · LYRICA · MYOBLOC · Morphabond ER · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OSTEOCOOL RF ABLATION · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · Protege Family of SCS IPGs · QUTENZA · RELISTOR ORAL · ReActiv8 · SCS IPGs · SCS leads · SPRINT PNS System · SUPERION · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · SiJoin · StabiliT · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · WaveWriter Alpha Prime 16 · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pain medicine in FL.

Equivalent to $2,155 per 100 Medicare services performed
Looking for a pain medicine in Port Charlotte?
Compare pain medicines in the Port Charlotte area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain Medicines within 10 mi
4
Per 100K population
2.1
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
3.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ball is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (speaking/promotional, top 1%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ball experienced with injection, midazolam hydrochloride, per 1 mg?
Based on Medicare claims data, Dr. Ball performed 1,699 injection, midazolam hydrochloride, per 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ball receive payments from pharmaceutical companies?
Yes. Dr. Ball received a total of $222,634 from 40 companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ball's costs compare to other pain medicines in Port Charlotte?
Dr. Ball's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ball) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →